Exelon Skin Patch For Treatment of Alzheimer's Disease Gets Approval
Alzheimer's Disease Treatment - Exelon
Once-daily skin patch offers novel approach to mild to moderate Alzheimer's disease treatment, providing smooth and continuous delivery of drug over 24 hours. Similar efficacy to highest doses of Exelon capsules with significant improvement in memory and ability to perform everyday activities compared to placebo.
Exelon Patch preferred by caregivers in a study because it helps manage patient care and gives visual reassurance that medication has been administered. Exelon Patch minimizes gastrointestinal side effects seen with oral form of drug.
Exelon Patch (rivastigmine transdermal system) has received its first worldwide approval in the United States as an innovative way to deliver an effective medicine for mild to moderate Alzheimer's disease patients through a skin patch instead of an oral capsule.